Chemagen Milestones & BioLegend Acquisition Mark Growth in Mag-Biotech at PerkinElmer
Signs of growth in its magnetic separations business are evident at PerkinElmer as its Chemagen unit in Germany marks 1 billion nucleic acid extractions, and the $5 billion acquisition of BioLegend in California adds to the portfolio. […]